Specification of arterial, venous, and lymphatic endothelial cells during embryonic development

Histology and Histopathology

Volumn 25, Issue 5, 2010, Pages 637-646

  Kume, Tsutomu ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Arterial venous specification; Fox; Lymphatic specification; Notch; VEGF

Indexed keywords

DANIO RERIO; MUS;

EPHRIN B2; FORKHEAD TRANSCRIPTION FACTOR; NOTCH RECEPTOR; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR SOX; VASCULOTROPIN A;

ANIMAL; ARTERY; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CYTOLOGY; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; FEMALE; GENETICS; LYMPH VESSEL; METABOLISM; MOUSE; PHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; REVIEW; SIGNAL TRANSDUCTION; VEIN; ZEBRA FISH;

ANIMALS; ARTERIES; CELL DIFFERENTIATION; EMBRYONIC DEVELOPMENT; ENDOTHELIAL CELLS; EPHRIN-B2; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HEDGEHOG PROTEINS; LYMPHATIC VESSELS; MICE; MODELS, BIOLOGICAL; PREGNANCY; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; SOX TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VEINS; ZEBRAFISH;

EID: 77953053518     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Adams R.H. and Alitalo K. (2007). Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell. Biol. 8, 464-478.
2. Adams R.H., Wilkinson G.A., Weiss C., Diella F., Gale N.W., Deutsch U., Risau W. and Klein R. (1999). Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 13, 295-306.
3. Aitsebaomo J., Portbury A.L., Schisler J.C. and Patterson C. (2008). Brothers and sisters: molecular insights into arterial-venous heterogeneity. Circ. Res. 103, 929-939.
4. Byrd N., Becker S., Maye P., Narasimhaiah R., St-Jacques B., Zhang X., McMahon J., McMahon A. and Grabel L. (2002). Hedgehog is required for murine yolk sac angiogenesis. Development 129, 361-372.
5. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W. and Nagy A. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439.
6. Cermenati S., Moleri S., Cimbro S., Corti P., Del Giacco L., Amodeo R., Dejana E., Koopman P., Cotelli F. and Beltrame M. (2008). Sox18 and Sox7 play redundant roles in vascular development. Blood 111, 2657-2666.
7. Chun C.Z., Kaur S., Samant G.V., Wang L., Pramanik K., Garnaas M.K., Li K., Field L., Mukhopadhyay D. and Ramchandran R. (2009). Snrk-1 is involved in multiple steps of angioblast development and acts via notch signaling pathway in artery-vein specification in vertebrates. Blood 113, 1192-1199.
8. Covassin L.D., Villefranc J.A., Kacergis M.C., Weinstein B.M. and Lawson N.D. (2006). Distinct genetic interactions between multiple Vegf receptors are required for development of different blood vessel types in zebrafish. Proc. Natl. Acad. Sci. USA 103, 6554-6559.
9. Covassin L.D., Siekmann A.F., Kacergis M.C., Laver E., Moore J.C., Villefranc J.A., Weinstein B.M. and Lawson N.D. (2009). A genetic screen for vascular mutants in zebrafish reveals dynamic roles for Vegf/Plcg1 signaling during artery development. Dev. Biol. 329, 212-226.
10. Duarte A., Hirashima M., Benedito R., Trindade A., Diniz P., Bekman E., Costa L., Henrique D. and Rossant J. (2004). Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev. 18, 2474-2478.
11. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.J. and Moore M.W. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442.
12. Fischer A., Schumacher N., Maier M., Sendtner M. and Gessler M. (2004). The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 18, 901-911.
13. Francois M., Caprini A., Hosking B., Orsenigo F., Wilhelm D., Browne C., Paavonen K., Karnezis T., Shayan R., Downes M., Davidson T., Tutt D., Cheah K.S., Stacker S.A., Muscat G.E., Achen M.G., Dejana E. and Koopman P. (2008). Sox18 induces development of the lymphatic vasculature in mice. Nature 456, 643-647.
14. Gale N.W., Dominguez M.G., Noguera I., Pan L., Hughes V., Valenzuela D.M., Murphy A.J., Adams N.C., Lin H.C., Holash J., Thurston G. and Yancopoulos G.D. (2004). Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc. Natl. Acad. Sci. USA 101, 15949-15954.
15. Gerety S.S. and Anderson D.J. (2002). Cardiovascular ephrinB2 function is essential for embryonic angiogenesis. Development 129, 1397-1410.
16. Gerety S.S., Wang H.U., Chen Z.F. and Anderson D.J. (1999). Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol. Cell 4, 403-414.
17. Grazia Lampugnani M., Zanetti A., Corada M., Takahashi T., Balconi G., Breviario F., Orsenigo F., Cattelino A., Kemler R., Daniel T.O. and Dejana E. (2003). Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J. Cell Biol. 161, 793-804.
18. Grego-Bessa J., Luna-Zurita L., del Monte G., Bolos V., Melgar P., Arandilla A., Garratt A.N., Zang H., Mukouyama Y.S., Chen H., Shou W., Ballestar E., Esteller M., Rojas A., Pérez-Pomares J.M. and de la Pompa J.L. (2007). Notch signaling is essential for ventricular chamber development. Dev. Cell 12, 415-429.
19. Gridley T. (2007). Notch signaling in vascular development and physiology. Development 134, 2709-2718.
20. Hayashi H. and Kume T. (2008). Foxc transcription factors directly regulate Dll4 and Hey2 expression by interacting with the VEGF-Notch signaling pathways in endothelial cells. PLoS ONE 3, e2401.
21. Herpers R., van de Kamp E., Duckers H.J. and Schulte-Merker S. (2008). Redundant roles for sox7 and sox18 in arteriovenous specification in zebrafish. Circ. Res. 102, 12-15.
22. Herzog Y., Kalcheim C., Kahane N., Reshef R. and Neufeld G. (2001). Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins. Mech. Dev. 109, 115-119.
23. Hong C.C., Peterson Q.P., Hong J.Y. and Peterson R.T. (2006). Artery/vein specification is governed by opposing phosphatidy-linositol-3 kinase and MAP kinase/ERK signaling. Curr. Biol. 16, 1366-1372.
24. Hong C.C., Kume T. and Peterson R.T. (2008). Role of crosstalk between phosphatidylinositol 3-kinase and extracellular signal-regulated kinase/mitogen-activated protein kinase pathways in artery-vein specification. Circ. Res. 103, 573-579.
25. Hong Y.K., Harvey N., Noh Y.H., Schacht V., Hirakawa S., Detmar M. and Oliver G. (2002). Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev. Dyn. 225, 351-357.
26. Hosking B., Francois M., Wilhelm D., Orsenigo F., Caprini A., Svingen T., Tutt D., Davidson T., Browne C., Dejana E. and Koopman P. (2009). Sox7 and Sox17 are strain-specific modifiers of the lymphangiogenic defects caused by Sox18 dysfunction in mice. Development 136, 2385-2391.
27. Johnson N.C., Dillard M.E., Baluk P., McDonald D.M., Harvey N.L., Frase S.L. and Oliver G. (2008). Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity. Genes Dev. 22, 3282-3291.
28. Jones E.A., Yuan L., Breant C., Watts R.J. and Eichmann A. (2008). Separating genetic and hemodynamic defects in neuropilin 1 knockout embryos. Development 135, 2479-2488.
29. Kaipainen A., Korhonen J., Mustonen T., van Hinsbergh V.W., Fang G.H., Dumont D., Breitman M. and Alitalo K. (1995). Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA 92, 3566-3570.
30. Karkkainen M.J., Haiko P., Sainio K., Partanen J., Taipale J., Petrova T.V., Jeltsch M., Jackson D.G., Talikka M., Rauvala H. Betsholtz C. and Alitalo K. (2004). Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5, 74-80.
31. Kiefer F. and Adams R.H. (2008). Lymphatic endothelial differentiation: start out with Sox-carry on with Prox. Genome Biol. 9, 243.
32. Kokubo H., Miyagawa-Tomita S., Nakazawa M., Saga Y. and Johnson R.L. (2005). Mouse hesr1 and hesr2 genes are redundantly required to mediate Notch signaling in the developing cardiovascular system. Dev. Biol. 278, 301-309.
33. Krebs L.T., Xue Y., Norton C.R., Shutter J.R., Maguire M., Sundberg J.P., Gallahan D., Closson V., Kitajewski J., Callahan R. Smith G.H., Stark K.L. and Gridley T. (2000). Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 14, 1343-1352.
34. Krebs L.T., Shutter J.R., Tanigaki K., Honjo T., Stark K.L. and Gridley T. (2004). Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev. 18, 2469-2473.
35. Kruse S.W., Suino-Powell K., Zhou X.E., Kretschman J.E., Reynolds R., Vonrhein C., Xu Y., Wang L., Tsai S.Y., Tsai M. J. and Xu H.E. (2008). Identification of COUP-TFII orphan nuclear receptor as a retinoic acid-activated receptor. PLoS Biol. 6, e227.
36. Kukk E., Lymboussaki A., Taira S., Kaipainen A., Jeltsch M., Joukov V. and Alitalo K. (1996). VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122, 3829-3837.
37. Kume T., Jiang H., Topczewska J.M. and Hogan B.L. (2001). The murine winged helix transcription factors, Foxc1 and Foxc2, are both required for cardiovascular development and somitogenesis. Genes Dev. 15, 2470-2482.
38. Lanner F., Sohl M. and Farnebo F. (2007). Functional arterial and venous fate is determined by graded VEGF signaling and notch status during embryonic stem cell differentiation. Arterioscler. Thromb. Vasc. Biol. 27, 487-493.
39. Lawson N.D., Scheer N., Pham V.N., Kim C.H., Chitnis A.B., Campos-Ortega J.A. and Weinstein B.M. (2001). Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 128, 3675-3683.
40. Lawson N.D., Vogel A.M. and Weinstein B.M. (2002). Sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev. Cell 3, 127-136.
41. Lawson N.D., Mugford J.W., Diamond B.A. and Weinstein B.M. (2003). phospholipase C gamma-1 is required downstream of vascular endothelial growth factor during arterial development. Genes Dev. 17, 1346-1351.
42. le Noble F., Moyon D., Pardanaud L., Yuan L., Djonov V., Matthijsen R., Breant C., Fleury V. and Eichmann A. (2004). Flow regulates arterial-venous differentiation in the chick embryo yolk sac. Development 131, 361-375.
43. Lee S., Kang J., Yoo J., Ganesan S.K., Cook S.C., Aguilar B., Ramu S., Lee J. and Hong Y.K. (2009). Prox1 physically and functionally interacts with COUP-TFII to specify lymphatic endothelial cell fate. Blood 113, 1856-1859.
44. Liu Z.J., Shirakawa T., Li Y., Soma A., Oka M., Dotto G.P., Fairman R.M., Velazquez O.C. and Herlyn M. (2003). Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol. Cell Biol. 23, 14-25.
45. Lohela M., Bry M., Tammela T. and Alitalo K. (2009). VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr. Opin. Cell Biol. 21, 154-165.
46. Maby-El Hajjami H. and Petrova T.V. (2008). Developmental and pathological lymphangiogenesis: from models to human disease. Histochem. Cell Biol. 130, 1063-1078.
47. Makinen T., Adams R.H., Bailey J., Lu Q., Ziemiecki A., Alitalo K., Klein R. and Wilkinson G.A. (2005). PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev. 19, 397-410.
48. Matsui T., Kanai-Azuma M., Hara K., Matoba S., Hiramatsu R., Kawakami H., Kurohmaru M., Koopman P. and Kanai Y. (2006). Redundant roles of Sox17 and Sox18 in postnatal angiogenesis in mice. J. Cell Sci. 119, 3513-3526.
49. Mishima K., Watabe T., Saito A., Yoshimatsu Y., Imaizumi N., Masui S., Hirashima M., Morisada T., Oike Y., Araie M., Niwa H., Kubo H., Suda T. and Miyazono K. (2007). Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades. Mol. Biol. Cell 18, 1421-1429.
50. Moyon D., Pardanaud L., Yuan L., Breant C. and Eichmann A. (2001). Plasticity of endothelial cells during arterial-venous differentiation in the avian embryo. Development 128, 3359-3370.
51. Mukouyama Y.S., Shin D., Britsch S., Taniguchi M. and Anderson D.J. (2002). Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell 109, 693-705.
52. Mukouyama Y.S., Gerber H.P., Ferrara N., Gu C. and Anderson D.J. (2005). Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1-mediated positive feedback. Development 132, 941-952.
53. Nicoli S., Tobia C., Gualandi L., De Sena G. and Presta M. (2008). Calcitonin receptor-like receptor guides arterial differentiation in zebrafish. Blood 111, 4965-4972.
54. Norrmen C., Ivanov K.I., Cheng J., Zangger N., Delorenzi M., Jaquet M., Miura N., Puolakkainen P., Horsley V., Hu J., Augustin H.G., Ylä-Herttuala S., Alitalo K. and Petrova T.V. (2009). FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J. Cell Biol. 185, 439-457.
55. Othman-Hassan K., Patel K., Papoutsi M., Rodriguez-Niedenfuhr M., Christ B. and Wilting J. (2001). Arterial identity of endothelial cells is controlled by local cues. Dev. Biol. 237, 398-409.
56. Papanicolaou K.N., Izumiya Y. and Walsh K. (2008). Forkhead transcription factors and cardiovascular biology. Circ. Res. 102, 16-31.
57. Pendeville H., Winandy M., Manfroid I., Nivelles O., Motte P., Pasque V., Peers B., Struman I., Martial J.A. and Voz M.L. (2008). Zebrafish Sox7 and Sox18 function together to control arterial-venous identity. Dev. Biol. 317, 405-416.
58. Peterson R.T., Shaw S.Y., Peterson T.A., Milan D.J., Zhong T.P., Schreiber S.L., MacRae C.A. and Fishman M.C. (2004). Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat. Biotechnol. 22, 595-599.
59. Petrova T.V., Makinen T., Makela T.P., Saarela J., Virtanen I., Ferrell R.E., Finegold D.N., Kerjaschki D., Yla-Herttuala S. and Alitalo K. (2002). Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J. 21, 4593-4599.
60. Petrova T.V., Karpanen T., Norrmen C., Mellor R., Tamakoshi T., Finegold D., Ferrell R., Kerjaschki D., Mortimer P., Yla-Herttuala S. Miura N. and Alitalo K. (2004). Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat. Med. 10, 974-981.
61. Pramanik K., Chun C.Z., Garnaas M.K., Samant G.V., Li K., Horswill M.A., North P.E. and Ramchandran R. (2009). Dusp-5 and Snrk-1 coordinately function during vascular development and disease. Blood 113, 1184-1191.
62. Rodriguez F., Vacaru A., Overvoorde J. and den Hertog J. (2008). The receptor protein-tyrosine phosphatase, Dep1, acts in arterial/venous cell fate decisions in zebrafish development. Dev. Biol. 324, 122-130.
63. Rutenberg J.B., Fischer A., Jia H., Gessler M., Zhong T.P. and Mercola M. (2006). Developmental patterning of the cardiac atrioventricular canal by Notch and Hairy-related transcription factors. Development 133, 4381-4390.
64. Sakamoto Y., Hara K., Kanai-Azuma M., Matsui T., Miura Y., Tsunekawa N., Kurohmaru M., Saijoh Y., Koopman P. and Kanai Y. (2007). Redundant roles of Sox17 and Sox18 in early cardiovascular development of mouse embryos. Biochem. Biophys. Res. Commun. 360, 539-544.
65. Seo S., Fujita H., Nakano A., Kang M., Duarte A. and Kume T. (2006). The forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development. Dev. Biol. 294, 458-470.
66. Shawber C.J., Funahashi Y., Francisco E., Vorontchikhina M., Kitamura Y., Stowell S.A., Borisenko V., Feirt N., Podgrabinska S., Shiraishi K., Chawengsaksophak K., Rossant J., Accili D., Skobe M. and Kitajewski J. (2007). Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. J. Clin. Invest. 117, 3369-3382.
67. Shin J.W., Min M., Larrieu-Lahargue F., Canron X., Kunstfeld R., Nguyen L., Henderson J.E., Bikfalvi A., Detmar M. and Hong Y.K. (2006). Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis. Mol. Biol. Cell. 17, 576-584.
68. Sorensen I., Adams R.H. and Gossler A. (2009). DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries. Blood 113, 5680-5688.
69. Srinivasan R.S., Dillard M.E., Lagutin O.V., Lin F.J., Tsai S., Tsai M.J., Samokhvalov I.M. and Oliver G. (2007). Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. Genes Dev. 21, 2422-2432.
70. Stalmans I., Ng Y.S., Rohan R., Fruttiger M., Bouche A., Yuce A., Fujisawa H., Hermans B., Shani M., Jansen S., Hicklin D., Anderson D.J., Gardiner T., Hammes H.P., Moons L., Dewerchin M., Collen D., Carmeliet P. and D'Amore P.A. (2002). Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J. Clin. Invest. 109, 327-336.
71. Swift M.R. and Weinstein B.M. (2009). Arterial-venous specification during development. Circ. Res. 104, 576-588.
72. Timmerman L.A., Grego-Bessa J., Raya A., Bertran E., Perez-Pomares J.M., Diez J., Aranda S., Palomo S., McCormick F., Izpisua-Belmonte J.C. and de la Pompa J.L. (2004). Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 18, 99-115.
73. van Tuyl M., Groenman F., Wang J., Kuliszewski M., Liu J., Tibboel D. and Post M. (2007). Angiogenic factors stimulate tubular branching morphogenesis of sonic hedgehog-deficient lungs. Dev. Biol. 303, 514-526.
74. Vokes S.A., Yatskievych T.A., Heimark R.L., McMahon J., McMahon A.P., Antin P.B. and Krieg P.A. (2004). Hedgehog signaling is essential for endothelial tube formation during vasculogenesis. Development 131, 4371-4380.
75. Wang H.U., Chen Z.F. and Anderson D.J. (1998). Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93, 741-753.
76. Wigle J.T. and Oliver G. (1999). Prox1 function is required for the development of the murine lymphatic system. Cell 98, 769-778.
77. Wigle J.T., Harvey N., Detmar M., Lagutina I., Grosveld G., Gunn M.D., Jackson D.G. and Oliver G. (2002). An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 21, 1505-1513. (Pubitemid 34614607)
78. Yamazaki T., Yoshimatsu Y., Morishita Y., Miyazono K. and Watabe T. (2009). COUP-TFII regulates the functions of Prox1 in lymphatic endothelial cells through direct interaction. Genes Cells 14, 425-434.
79. You L.R., Lin F.J., Lee C.T., DeMayo F.J., Tsai M.J. and Tsai S.Y. (2005). Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 435, 98-104.
80. Yuan L., Moyon D., Pardanaud L., Breant C., Karkkainen M.J., Alitalo K. and Eichmann A. (2002). Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129, 4797-4806.
81. Yurugi-Kobayashi T., Itoh H., Schroeder T., Nakano A., Narazaki G., Kita F., Yanagi K., Hiraoka-Kanie M., Inoue E., Ara, T., Nagasawa T., Just U., Nakao K., Nishikawa S., Yamashita J.K. (2006). Adrenomedullin/cyclic AMP pathway induces Notch activation and differentiation of arterial endothelial cells from vascular progenitors. Arterioscler. Thromb. Vasc. Biol. 26, 1977-1984.
82. Zhong T.P., Childs S., Leu J.P. and Fishman M.C. (2001). Gridlock signalling pathway fashions the first embryonic artery. Nature 414, 216-220.